What is the difference between approval, authorization, and clearance?

  • Share:

Approval vs Authorization vs Clearance

The terms “approval,” “authorization,” and “clearance” are often used interchangeably in discussions of the COVID-19 vaccines. What do they really mean? Let’s take a closer look.

Authorization

An Emergency Use Authorization allows for the short-term use of a medical product.

The FDA expects that the sponsor will be building a formal Biologic License Application (BLA) for when the public emergency has passed.

Approval

“Approval” refers to the approval of a full application package:

  • Pre-Market Approval (PMA) for medical devises.
  • New Drug Application (NDA) approval for small molecules.
  • Biologics License Application (BLA) approval for biologics, including vaccines.

Clearance

Clearance is a more abbreviated process than an approval

  • Clinical trials for small molecules and biologics are considered “cleared” if the FDA does not provide negative feedback within 30 days of the Investigational New Drug (IND) application.
  • A medical device that is not novel and similar to an already approved device undergoes a process known as 510(k) clearance before entering the market.

Contact us so that we help your company navigate the many other complexities of launching your drug, biologic or medical device.

  • Share:

Explore Solutions

Let’s Get Started

Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.

1.877.787.0177

22320 Foothill Blvd. Suite 330, Hayward CA 94541